Company / Tangible Book Value per Share
NOVAVAX INC Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$1.50
FY2025
5-year range
-$9.81 / $6.54
FY2021-FY2025
Trend
+71.3%
vs FY2024
Sector context
#192 of 209
Health Care
What the data says
Among 209 Health Care companies, NOVAVAX INC is in the bottom 8% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-9.81 in FY2023 to $15.20 in FY2020.
Based on SEC 10-K filings.
-1.50 in FY2025.
Improved from $-9.81 to $-1.50 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 209This company -$1.50 Sector average $119.74
▼
-101.3% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 71.3% year-over-year.
- Ranks #192 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2020.
- Lowest tangible book value per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.50 | +71.3% |
| FY2024 | -$5.24 | +46.6% |
| FY2023 | -$9.81 | -250.1% |
| FY2022 | $6.54 | +196.0% |
| FY2021 | -$6.81 | -144.8% |
| FY2020 | $15.20 | +290.1% |
| FY2019 | -$8.00 | -4272.4% |
| FY2018 | -$0.18 | -120.6% |
| FY2017 | $0.89 | +35.9% |
| FY2016 | $0.65 | +5.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026